Pharma

PHARMACEUTICAL COLLABORATORS

About Mary Crowley Cancer Research

 

Mary Crowley Cancer Research (MCCR) is an independent, nonprofit oncology research center established in 1997. Founded by Mary C. Crowley, our mission is to expand treatment options for all cancer patients through investigational cellular, gene, and immune therapies.

MCCR has conducted 645+ clinical trials for 7000+ patients in collaboration with 290+ different pharmaceutical partners. MCCR is designed, equipped, and staffed for conducting early phase solid tumor and hematology trials, including performing 80+ first-in-human trials.

An Accelerated Approach to Cancer Research

 

Study Start-Up Patient Population Data
  • 8 - 10 weeks from receipt of final protocol - may be shorter under our Just-in-Time (JIT) program
  • Parallel completion of all startup activities
  • Prompt review/approval - local Institutional Review Board meets weekly
  • Referral base of over 420 oncologists
  • Robust Molecular Registry - reportable for rapid enrollment
  • Outreach team focused on educating community oncologists of trials and their technology
  • 70/70 Successful MQA Audits
  • 6/6 Successful FDA Audits
  • Data team located within clinic to expedite data entry timelines

                                                                                   Our Facilities

 

The Clinic

  • State-of-the-Art, 14,000 square foot clinic located on the campus of Medical City Hospital, Dallas.
  • Dedicated research clinical staff (CRNs, CRC, PharmD, and supporting personnel)
  • 13 infusion chairs
  • Integrated research-only pharmacy
  • BSL II compliant isolation rooms
  • Specialized laboratory processing (including PBMCs)

The Administrative Offices

  • 16,000 square foot administrative office space
  • Dedicated research employees (Finance, Legal, Project Management, Regulatory, IRB, Marketing/Business Development, Leadership)
  • Monitoring suites with high-speed internet access

Processes

Below are links to an overview of our site’s processes, divided into Clinical and Administrative duties.

Central Site Process

Central Site Process

Medical City Process

Medical City Process

FOR MORE INFORMATION, CONTACT:

Alisha Myers, Study Development Manager, and Tina Nghiem, Associate Director, Clinical Trial Development, at pharma@marycrowley.org

Celebrating 20 Years